NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

I think it really depends on what kind of information they want from the long survival tail. If you live 36 months, what are your chances of living 60 months? They seem to really want to get as much data as they can about the tail. That is the hold up here.

Any way you plot it, the mOS at this point in the trial will beat historical SOC by months. But they’re trying to glean statistically significant information about the tail. That seems to be the new value to patients from this trial. Our principal investigator once again is advocating for patients. Kudos to her.

Shame on the FDA for not getting access to people for this vaccine based on early and interm blinded data. They seem to be on the side of being overly cautious while patients continue to suffer from lack of treatment options for GBM.